Council of Early Career Investigators in Imaging (CECI²)2026-09-23T14:25:51-04:00

We are pleased to announce the 2026-2027 CECI² class!

View the 2026-27 CECI² class announcement here.

Academy Council of Early Career Investigators in Imaging (CECI²)

The Academy Council consists of a network of more than 200 imaging investigators from 50 academic research departments. The purpose of this Council is to recognize and encourage the early career achievements of researchers, engage them in advocacy for research funding, create cross institutional educational programming and facilitate diverse networking opportunities. The advocacy efforts and opportunities are led by Academy staff. A year-long virtual program is designed by the investigators themselves, who are most suited to identify what they need and how they can best benefit from Academy resources. The 2026-2027 CECI planning committee members are listed below.

Have questions about the Council or the nomination process? Reach out! You can email Olivia Nelson, onelson@acadrad.org, with any inquiries.

2026-2027 CECI2 Class Announcement

All CECI2 Events and Resources

CECI2 Directory

2026 Academy Events Summary

CECI2 Alumni Testimonials

Advocacy for Imaging feat. CECI2 Members

Hear directly from our CECI2 Members in this brief video:

Academy’s Annual Medical Imaging
Technology Showcase 2026 (MedTech26)

MedTech allows early career investigators to display hands-on, interactive, and informative examples of their research efforts to policymakers, representatives from NIH, Academy leadership, patient advocacy groups and industry.

Please view the video below for an overview of our event this year in the Rayburn Congressional House Office Building:

The CECI² Experience 

“[The Academy] takes us to the background, where we see that it is actually the American people through the government, through NIH that funds us. It made me realize that it’s also our job as researchers to advocate for funding and show everyone that it is worth investing in us because that will lead to improved healthcare and better quality of life.”
Carolina de Aguiar Ferreira, PharmD, PhD
Class of 2023-24, Assistant Professor, Michigan State University

“It has been a very unique program in the sense that it offers something that I haven’t experienced before. What we’ve been taught about is advocacy and the importance of funding, and how we as researchers can impact that funding, which is something that you don’t hear anywhere else.”
Katja De Paepe, MD, PhD
Class of 2023-24, Beth Israel Deaconess Medical Center

CECI² CO-CHAIRS & LEADERSHIP POSITIONS

To advance the daily efforts of this program, the Academy announced the important addition of two new leadership positions within the Council as well as a CECI² Advisory Council in 2021.

Academy's CECI² Virtual Programming Committee

This committee plans all virtual sessions to ensure that each session addresses the current needs of early career investigators from across all academic institutions of various size, funding and research areas.

Rebecca Rakow-Penner, MD, PhD

Anton Becker, MD, PhD
Assistant Professor, New York University, CECI² Class of 2020-21

Aisling Chaney, Phd

Aisling Chaney, PhD
Assistant Professor of Radiology, Washington University, St. Louis, CECI² Class of 2020-21

Devaki Shilpa Surasi

Devaki Shilpa Surasi, MBBS, CMQ
Associate Professor, The University of Texas MD Anderson Cancer Center, CECI² Class of 2023-24

Alexander Goehler, MD

Vivek Yedavalli, MD, MS
Chief of Neuroradiology, Johns Hopkins Bayview Medical Center, CECI² Class of 2022

Benjamin Larimer

Benjamin Larimer, PhD
Associate Professor, Division of Advanced Medical Imaging Research, University of Alabama at Birmingham, CECI² Class of 2020-21

Academy's CECI² Advisory Council

This Committee offers important perspectives and advice throughout the planning and execution of future CECI² class’s programing, as well as helping the Academy capitalize on our growing alumni network. The committee includes the two current Co-Chairs of this council as well as the below past council Co-Chairs.

Rebecca Rakow-Penner, MD, PhD

Rebecca Rakow-Penner, MD, PhD
Assistant Professor of Radiology, University of California, San Diego, CECI² Class of 2014

Jadranka Stojanovska, MD

Jadranka Stojanovska, MD
Associate Professor, Radiology, New York University, CECI² Class of 2014

Samuel Galgano, MD

Samuel Galgano, MD
Assistant Professor, Abdominal Imaging Section and Division of Molecular Imaging and Therapeutics, CECI² Class of 2018

Alexander Goehler, MD

Alexander Goehler, MD
Executive Director, Precision Medicine Imaging and AI, Novartis Institutes for Biomedical Research, Cambridge MA, CECI² Class of 2018

Why nominate an early career researcher from your institution?

Academy leaders offer their perspective on the value of CECI².

CECI Washington

2023-24 CECI² Class by Degree

CECI 2023 Class by degrees

2023-24 CECI² Class by Society

The CECI² program is specifically for Academy member societies, departments and companies. Applications must come directly from the academic chair, executive director or company representative.

Purpose:

The Academy for Radiology & Biomedical Imaging Research created the Council of Early Career Investigators in Imaging (CECI²) in 2014 to recognize the achievements of researchers who are in the early phases of their careers and engage them in our advocacy for research funding.

Since its establishment, the CECI² program has continued to develop and become increasingly impactful, having now reached over 180 young investigators. With a mix of both MD and PhD’s alike, early career investigators have been nominated or sponsored by Academy member departments and societies. As the program matures, our goal with its expansion is to increase opportunities to engage even more investigators from within our robust membership.

Criteria:

Nominated by the Chair or Vice Chair for Research, Executive Director of Academy Member Society or Industry Partner of the Academy, the main criteria for consideration are their potential in securing an NIH RO1 in the future (based on RSNA grants, K awards and other society awards), their status as an “early career investigator” (ESI), as per the NIH’s definition, and by illustrating clearly their interest in the mission of the Academy.

Process:

Academy members are invited to nominate ONE early career investigator to represent their department/society/company to the Council.

Leadership:

Current CECI2 co-chairs:
Dr. Natasha Sheybani, University of Virginia, Dr. Vivek Yedavalli, Johns Hopkins University

Who do I contact with questions?
Please address questions to Renee Cruea, Executive Director at rcruea@acadrad.org.

Go to Top